Trial intelligence / Profile preview

H1N1 2009 Vaccine with/without MF59 in Children

NCT00996307Phase 3Completed

Sponsor
Novartis
Start
Oct 2009
Primary completion
Dec 2009
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 3 trial of influenza A (H1N1) 2009 monovalent subunit vaccine in influenza A H1N1 infection (H1N1), sponsored by Novartis. Started Oct 2009; status: completed.

02

Drugs

influenza A (H1N1) 2009 monovalent subunit vaccine
03

Conditions

influenza A H1N1 infection (H1N1)

Beyond the preview

Go deeper on NCT00996307.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00996307.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call